Found: 1
Select item for more details and to access through your institution.
In-House Implementation of Tumor Mutational Burden Testing to Predict Durable Clinical Benefit in Non-Small Cell Lung Cancer and Melanoma Patients.
- Published in:
- Cancers, 2019, v. 11, n. 9, p. 1271, doi. 10.3390/cancers11091271
- By:
- Publication type:
- Article